About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford-AstraZeneca COVID-19 vaccine were given the wrong dose, but were not informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters news agency show.
Instead, the dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses. The letter was signed by the trial’s chief investigator, Oxford professor Andrew Pollard, and sent to the trial subjects.
As Reuters reported on December 24, participants were given about a half-dose due to a measuring mistake by Oxford researchers. The Pollard letter did not acknowledge any error. Nor did it disclose that researchers had reported the issue to British medical regulators, who then told Oxford to add another test group to receive the full dose, in line with the trial’s original plan.
Covid-19: 1500 volontaires ont reçu une dose réduite du vaccin AstraZeneca, sans jamais avoir été prévenus
bfmtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bfmtv.com Daily Mail and Mail on Sunday newspapers.
Universidad de Oxford no informó a voluntarios de vacuna covid-19 sobre equivocación en dosis
elcomercio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elcomercio.com Daily Mail and Mail on Sunday newspapers.